EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Estrogen Receptor Signaling in the Immune System

Binita Chakraborty, Jovita Byemerwa, Taylor Krebs, Felicia Lim, Ching-Yi Chang, Donald P McDonnell iD

Endocrine Reviews · 12.01.2023 · 44 (1) · 117-141

DOI: 10.1210/endrev/bnac017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 16.06.2022. Verfasst von Binita Chakraborty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Receptors, Estrogen, Estrogens. Die Arbeit wurde bisher 276-mal zitiert (Crossref) und nennt 304 Literaturangaben. Gefördert von: NCI NIH HHS, Melanoma Research Foundation, Department of Defense Innovator.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune system functions in a sexually dimorphic manner, with females exhibiting more robust immune responses than males. However, how female sex hormones affect immune function in normal homeostasis and in autoimmunity is poorly understood. In this review, we discuss how estrogens affect innate and adaptive immune cell activity and how dysregulation of estrogen signaling underlies the pathobiology of some autoimmune diseases and cancers. The potential roles of the major circulating estrogens, and each of the 3 estrogen receptors (ERα, ERβ, and G-protein coupled receptor) in the regulation of the activity of different immune cells are considered. This provides the framework for a discussion of the impact of ER modulators (aromatase inhibitors, selective estrogen receptor modulators, and selective estrogen receptor downregulators) on immunity. Synthesis of this information is timely given the considerable interest of late in defining the mechanistic basis of sex-biased responses/outcomes in patients with different cancers treated with immune checkpoint blockade. It will also be instructive with respect to the further development of ER modulators that modulate immunity in a therapeutically useful manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, EstrogenEstrogensMaleHumansFemaleSelective Estrogen Receptor ModulatorsEstrogen Receptor betaEstrogen Receptor alphaImmune SystemEstradiol

Stichwörter der Autor:innen

17β-estradiolautoimmunitycancerimmune checkpoint blockadeselective estrogen receptor degraderselective estrogen receptor modulatortumor microenvironment

Substanzen

Receptors, EstrogenEstrogensSelective Estrogen Receptor ModulatorsEstrogen Receptor betaEstrogen Receptor alphaEstradiol

Autor:innen und Institutionen

  • Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA.
  • Known Medicine, Salt Lake City, UT 84108, USA.

ORCID-Profile: Donald P McDonnell

Förderung

  • NCI NIH HHS
  • Melanoma Research Foundation
  • Department of Defense Innovator

Zitieren

APA

Chakraborty, B., Byemerwa, J., Krebs, T., Lim, F., Chang, C. Y., & McDonnell, D. P. (2023). Estrogen Receptor Signaling in the Immune System. Endocrine Reviews, 44(1), 117-141. https://doi.org/10.1210/endrev/bnac017

Vancouver

Chakraborty B, Byemerwa J, Krebs T, Lim F, Chang CY, McDonnell DP. Estrogen Receptor Signaling in the Immune System. Endocrine Reviews. 2023;44(1):117-141. doi:10.1210/endrev/bnac017

BibTeX
@article{Chakraborty2023,
  author = {Chakraborty, Binita and Byemerwa, Jovita and Krebs, Taylor and Lim, Felicia and Chang, Ching-Yi and McDonnell, Donald P},
  title = {Estrogen Receptor Signaling in the Immune System},
  journal = {Endocrine Reviews},
  year = {2023},
  volume = {44},
  number = {1},
  pages = {117--141},
  doi = {10.1210/endrev/bnac017}
}
Kostenlos starten →